Literature DB >> 23126488

A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar.

Moein Momtazi1, Peter Kwan, Jie Ding, Colin C Anderson, Dariush Honardoust, Serge Goekjian, Edward E Tredget.   

Abstract

Hypertrophic scar (HSc) is a fibroproliferative disorder that occurs following deep dermal injury. Lack of a relevant animal model is one barrier toward better understanding its pathophysiology. Our objective is to demonstrate that grafting split-thickness human skin onto nude mice results in survival of engrafted human skin and murine scars that are morphologically, histologically, and immunohistochemically consistent with human HSc. Twenty nude mice were xenografted with split-thickness human skin. Animals were euthanized at 30, 60, 120, and 180 days postoperatively. Eighteen controls were autografted with full-thickness nude mouse skin and euthanized at 30 and 60 days postoperatively. Scar biopsies were harvested at each time point. Blinded scar assessment was performed using a modified Manchester Scar Scale. Histologic analysis included hematoxylin and eosin, Masson's trichrome, toluidine blue, and picrosirius red staining. Immunohistochemistry included anti-human human leukocyte antigen-ABC, α-smooth muscle actin, decorin, and biglycan staining. Xenografted mice developed red, shiny, elevated scars similar to human HSc and supported by blinded scar assessment. Autograft controls appeared morphologically and histologically similar to normal skin. Xenografts survived up to 180 days and showed increased thickness, loss of hair follicles, adnexal structures and rete pegs, hypercellularity, whorled collagen fibers parallel to the surface, myofibroblasts, decreased decorin and increased biglycan expression, and increased mast cell density. Grafting split-thickness human skin onto nude mice results in persistent scars that show morphologic, histologic, and immunohistochemical consistency with human HSc. Therefore, this model provides a promising technique to study HSc formation and to test novel treatment options.
© 2012 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126488     DOI: 10.1111/j.1524-475X.2012.00856.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  18 in total

Review 1.  The Role of Chemokines in Fibrotic Wound Healing.

Authors:  Jie Ding; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

2.  Changes in dermal matrix in the absence of Rac1 in keratinocytes.

Authors:  Alanna Stanley; Esben Pedersen; Cord Brakebusch; Fabio Quondamatteo
Journal:  J Anat       Date:  2016-02-18       Impact factor: 2.610

3.  Survival of human cadaver skin on severe combined immune deficiency pigs: Proof of concept.

Authors:  Adam J Singer; Christopher Tuggle; Amanda Ahrens; Mary Sauer; Steve A McClain; Edward Tredget; Lior Rosenberg
Journal:  Wound Repair Regen       Date:  2019-03-19       Impact factor: 3.617

Review 4.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

5.  Macrophage-derived GPNMB accelerates skin healing.

Authors:  Walison N Silva; Pedro H D M Prazeres; Ana E Paiva; Luiza Lousado; Anaelise O M Turquetti; Rodrigo S N Barreto; Erika Costa de Alvarenga; Maria A Miglino; Ricardo Gonçalves; Akiva Mintz; Alexander Birbrair
Journal:  Exp Dermatol       Date:  2018-04-30       Impact factor: 3.960

6.  A Novel Nude Mouse Model of Hypertrophic Scarring Using Scratched Full Thickness Human Skin Grafts.

Authors:  Saad M Alrobaiea; Jie Ding; Zengshuan Ma; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-07-01       Impact factor: 4.730

7.  Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors.

Authors:  Miguel Perez-Aso; M Carmen Montesinos; Aránzazu Mediero; Tuere Wilder; Peter H Schafer; Bruce Cronstein
Journal:  Arthritis Res Ther       Date:  2015-09-15       Impact factor: 5.156

Review 8.  Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective.

Authors:  Lenie J van den Broek; Grace C Limandjaja; Frank B Niessen; Susan Gibbs
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

Review 9.  Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring.

Authors:  Kenneth W Finnson; Sarah McLean; Gianni M Di Guglielmo; Anie Philip
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-06       Impact factor: 4.730

10.  Establishing a Reproducible Hypertrophic Scar following Thermal Injury: A Porcine Model.

Authors:  Scott J Rapp; Aaron Rumberg; Marty Visscher; David A Billmire; Ann S Schwentker; Brian S Pan
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.